drugset / Trial / NCT04480281

Intravenous Lidocaine in Open Lung Resection Surgery

NCT04480281 ↗

Phase 4 Completed 60 enrolled Saint-Joseph University
RandomizedParallel-groupDouble-blindTreatment

Summary

Management of postoperative pain in 2020 remains a challenge for anesthesiologists in the perioperative period. Lidocaine is an amide local anesthetic, it is one of the oldest adjuvant analgesics and is known to possess analgesic, anti-hyperalgesic and anti-inflammatory properties. Lidocaine is proven to be as effective as epidural analgesia in colorectal surgery. However, no study has evaluated the effect of a continuous lidocaine infusion for open lung resection in the post-operative period. The present study aims to evaluate the influence of IV lidocaine given during and 24 hours after surgery, on pain scores, opioid consumption, and possible benefits on patient outcome via the opioid-sparing effect in open thoracic surgery

Timeline

Start
2020-01-10
Primary completion
2020-05-15
Completion
2020-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.